Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05329532
Title Modi-1 in Breast, Head and Neck, Ovarian, or Renal Cancer (ModiFY)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Scancell Ltd
Indications

hypopharynx cancer

renal cell carcinoma

triple-receptor negative breast cancer

peritoneum cancer

oropharynx cancer

fallopian tube cancer

laryngeal squamous cell carcinoma

ovarian serous carcinoma

oral cavity cancer

Therapies

Modi-1

Modi-1 + Pembrolizumab

Age Groups: adult | senior
Covered Countries


No variant requirements are available.